Dr. William Justiz, MD

Neurology Naples, FL Male
NPI: 1275583916
Total Payments
$135,961
2024 Payments
$14,305
Companies
49
Transactions
389
Medicare Patients
5,299
Medicare Billing
$878,083

Payment Breakdown by Category

Research$123,390 (90.8%)
Food & Beverage$8,536 (6.3%)
Travel$3,945 (2.9%)
Other$71.50 (0.1%)
Education$19.24 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $123,390 22 90.8%
Food and Beverage $8,536 345 6.3%
Travel and Lodging $3,945 15 2.9%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $71.50 3 0.1%
Education $19.24 4 0.0%

Payments by Type

Research
$123,390
22 transactions
General
$12,572
367 transactions

Top Paying Companies

Company Total Records Latest Year
ACADIA Pharmaceuticals Inc $86,894 47 $0 (2022)
Eli Lilly and Company $37,109 6 $0 (2024)
Merck Sharp & Dohme LLC $2,096 15 $0 (2024)
Alnylam Pharmaceuticals Inc. $1,372 10 $0 (2023)
Sage Therapeutics, Inc. $1,227 6 $0 (2023)
Novartis Pharmaceuticals Corporation $1,021 66 $0 (2024)
Janssen Research & Development, LLC $812.50 6 $0 (2024)
Sunovion Pharmaceuticals Inc. $774.82 23 $0 (2021)
Biogen, Inc. $538.12 12 $0 (2024)
ABBVIE INC. $537.20 31 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $14,305 61 Eli Lilly and Company ($11,500)
2023 $4,474 57 Alnylam Pharmaceuticals Inc. ($1,351)
2022 $2,258 44 Merck Sharp & Dohme LLC ($1,287)
2021 $24,988 32 Eli Lilly and Company ($24,440)
2020 $359.97 21 Novartis Pharmaceuticals Corporation ($147.45)
2019 $680.44 50 Novartis Pharmaceuticals Corporation ($133.03)
2018 $54,646 72 ACADIA Pharmaceuticals Inc ($53,064)
2017 $34,251 52 ACADIA Pharmaceuticals Inc ($33,487)

All Payment Transactions

389 individual payment records from CMS Open Payments — Page 1 of 16

Date Company Product Nature Form Amount Type
12/19/2024 ABBVIE INC. VYALEV (Drug) Food and Beverage In-kind items and services $13.72 General
Category: NEUROSCIENCE
12/10/2024 Lilly USA, LLC AMYVID (Drug), KISUNLA Food and Beverage In-kind items and services $17.64 General
Category: Neuroscience
12/06/2024 ABBVIE INC. BOTOX (Biological) Food and Beverage In-kind items and services $27.87 General
Category: BOTOX THERAPEUTIC
11/25/2024 ABBVIE INC. VYALEV (Drug) Food and Beverage In-kind items and services $5.93 General
Category: NEUROSCIENCE
11/21/2024 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $32.96 General
Category: Neurology
11/13/2024 Merck Sharp & Dohme LLC — Travel and Lodging In-kind items and services $202.27 General
Category: NEUROSCIENCE
11/13/2024 Merck Sharp & Dohme LLC — Food and Beverage In-kind items and services $65.00 General
Category: NEUROSCIENCE
11/13/2024 Merck Sharp & Dohme LLC — Food and Beverage In-kind items and services $59.94 General
Category: NEUROSCIENCE
11/13/2024 Merck Sharp & Dohme LLC — Food and Beverage In-kind items and services $55.00 General
Category: NEUROSCIENCE
11/12/2024 Merck Sharp & Dohme LLC — Travel and Lodging In-kind items and services $202.27 General
Category: NEUROSCIENCE
11/12/2024 Merck Sharp & Dohme LLC — Food and Beverage In-kind items and services $149.93 General
Category: NEUROSCIENCE
11/12/2024 Merck Sharp & Dohme LLC — Travel and Lodging Cash or cash equivalent $74.90 General
Category: NEUROSCIENCE
11/07/2024 GE HEALTHCARE — Food and Beverage In-kind items and services $16.35 General
10/25/2024 ABBVIE INC. VYALEV (Drug), DUOPA Food and Beverage In-kind items and services $12.52 General
Category: NEUROSCIENCE
10/21/2024 GE HEALTHCARE — Food and Beverage In-kind items and services $19.68 General
10/17/2024 Novartis Pharmaceuticals Corporation KESIMPTA (Drug) Food and Beverage In-kind items and services $33.45 General
Category: Neurology
10/16/2024 Eisai Inc. Leqembi (Drug) Food and Beverage In-kind items and services $14.87 General
Category: Neurology
10/01/2024 Eisai Inc. Leqembi (Drug) Food and Beverage In-kind items and services $27.85 General
Category: Neurology
09/24/2024 Lilly USA, LLC AMYVID (Drug), KISUNLA Food and Beverage In-kind items and services $20.86 General
Category: Neuroscience
09/20/2024 Janssen Research & Development, LLC — Food and Beverage In-kind items and services $52.86 General
09/20/2024 Janssen Research & Development, LLC — Food and Beverage In-kind items and services $38.44 General
09/20/2024 Janssen Research & Development, LLC — Food and Beverage In-kind items and services $19.23 General
09/20/2024 Janssen Research & Development, LLC — Food and Beverage In-kind items and services $19.23 General
09/19/2024 Janssen Research & Development, LLC — Travel and Lodging In-kind items and services $469.07 General
09/19/2024 Janssen Research & Development, LLC — Travel and Lodging In-kind items and services $213.67 General
123…16»

Research Studies & Clinical Trials

Study Name Company Amount Records
ACP-103-045 ACADIA Pharmaceuticals Inc $63,942 8
ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF DONANEMAB IN EARLY SYMPTOMATIC ALZHEIMERS DISEASE Eli Lilly and Company $24,740 3
ACP-103-033 ACADIA Pharmaceuticals Inc $16,271 3
EVALUATION OF THE LILLY SP-X P-TAU217 ASSAY BY MEASURING CHANGES IN THE INTENDED PATIENT MANAGEMENT BETWEEN PRE-AND POST-P-TAU217 RESULT: A RANDOMIZED CLINICAL UTILITY STUDY Eli Lilly and Company $11,500 1
ACP-103-032 ACADIA Pharmaceuticals Inc $4,308 4
ACP-103-015 ACADIA Pharmaceuticals Inc $1,760 1
ASSESSMENT OF SAFETY AND EFFICACY OF SUBCUTANEOUS REMTERNETUG IN EARLY SYMPTOMATIC ALZHEIMER'S DISEASE Eli Lilly and Company $458.68 1
A STUDY OF DONANEMAB (LY3002813) IN PARTICIPANTS WITH EARLY ALZHEIMER'S DISEASE (TRAILBLAZER-ALZ 2) Eli Lilly and Company $410.00 1

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 7 1,169 1,929 $729,631 $208,331
2022 10 1,310 1,948 $713,837 $215,757
2021 10 1,391 2,211 $690,730 $243,180
2020 11 1,429 2,182 $693,480 $210,815
Total Patients
5,299
Total Services
8,270
Medicare Billing
$878,083
Procedure Codes
38

All Medicare Procedures & Services

38 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 652 1,331 $444,554 $126,778 28.5%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 224 224 $127,789 $37,025 29.0%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 205 244 $115,363 $32,167 27.9%
95886 Needle measurement of electrical activity in arm or leg muscles, complete study Office 2023 45 87 $22,379 $6,646 29.7%
95910 Nerve conduction, 7-8 studies Office 2023 20 20 $9,067 $2,808 31.0%
95911 Nerve conduction, 9-10 studies Office 2023 11 11 $6,182 $1,866 30.2%
95909 Nerve conduction, 5-6 studies Office 2023 12 12 $4,296 $1,042 24.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 632 1,153 $368,694 $109,336 29.7%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 245 303 $134,811 $42,552 31.6%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 218 218 $123,597 $37,491 30.3%
95886 Needle measurement of electrical activity in arm or leg muscles, complete study Office 2022 74 133 $33,174 $11,071 33.4%
95909 Nerve conduction, 5-6 studies Office 2022 46 46 $16,348 $5,179 31.7%
95911 Nerve conduction, 9-10 studies Office 2022 20 20 $11,108 $3,394 30.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 31 31 $13,108 $2,633 20.1%
95910 Nerve conduction, 7-8 studies Office 2022 15 15 $7,048 $2,184 31.0%
99497 Advance care planning, first 30 minutes Office 2022 17 17 $3,142 $1,017 32.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 12 12 $2,808 $900.24 32.1%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 673 1,325 $371,270 $130,527 35.2%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 228 298 $112,050 $42,671 38.1%
99205 New patient outpatient visit, total time 60-74 minutes Office 2021 146 146 $76,650 $25,018 32.6%
95886 Needle measurement and recording of electrical activity of muscles of arm or leg complete study Office 2021 103 199 $44,775 $16,768 37.4%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 82 82 $34,030 $10,662 31.3%
95909 Nerve transmission studies, 5-6 studies Office 2021 78 78 $27,300 $8,993 32.9%
95910 Nerve transmission studies, 7-8 studies Office 2021 17 17 $8,075 $2,501 31.0%
95911 Nerve transmission studies, 9-10 studies Office 2021 12 12 $6,600 $2,247 34.0%
12»

About Dr. William Justiz, MD

Dr. William Justiz, MD is a Neurology healthcare provider based in Naples, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275583916.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Justiz, MD has received a total of $135,961 in payments from pharmaceutical and medical device companies, with $14,305 received in 2024. These payments were reported across 389 transactions from 49 companies. The most common payment nature is "" ($123,390).

As a Medicare-enrolled provider, Justiz has provided services to 5,299 Medicare beneficiaries, totaling 8,270 services with total Medicare billing of $878,083. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.

Practice Information

  • Specialty Neurology
  • Location Naples, FL
  • Active Since 05/11/2006
  • Last Updated 04/11/2024
  • Taxonomy Code 2084N0400X
  • Entity Type Individual
  • NPI Number 1275583916

Products in Payments

  • NUPLAZID (Drug) $86,894
  • APTIOM (Drug) $742.52
  • KESIMPTA (Drug) $493.37
  • BOTOX (Biological) $330.18
  • GILENYA (Drug) $268.56
  • Leqembi (Drug) $211.82
  • ZEPOSIA (Drug) $197.76
  • TECFIDERA (Drug) $194.48
  • TYSABRI (Biological) $191.62
  • Fintepla (Drug) $191.40
  • UPLIZNA (Drug) $175.28
  • DUOPA (Drug) $169.53
  • AMYVID (Drug) $160.31
  • VYEPTI (Biological) $145.94
  • GOCOVRI (Drug) $133.51
  • AIMOVIG (Biological) $115.78
  • Enspryng (Biological) $110.16
  • MAYZENT (Drug) $106.34
  • COPAXONE (Drug) $106.23
  • AJOVY (Drug) $101.06

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology Doctors in Naples

Matthew Baker, Md, MD

Neurology — Payments: $1.8M

Neurology $1.8M

Dr. Igor Reis, M.d, M.D

Neurology — Payments: $22,365

Neurology $22,365

Mark Rubino, Md, MD

Neurology — Payments: $21,523

Neurology $21,523

Ronald Howard, Md, MD

Neurology — Payments: $15,968

Neurology $15,968

Dr. Michael Novak, Md, MD

Neurology — Payments: $14,679

Neurology $14,679

Pedro Garciarena, M.d, M.D

Neurology — Payments: $14,132

Neurology $14,132